We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-2.63%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.26B
AUM Growth
-$529M
Cap. Flow
-$492M
Cap. Flow %
-21.74%
Top 10 Hldgs %
34.63%
Holding
101
New
12
Increased
22
Reduced
23
Closed
23

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$36.9M
2
DXCM icon
DexCom
DXCM
+$32.3M
3
BLUE
bluebird bio
BLUE
+$24.8M
4
ACHC icon
Acadia Healthcare
ACHC
+$24.2M
5
ASND icon
Ascendis Pharma A/S
ASND
+$23.1M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$46.8M
2
BIIB icon
Biogen
BIIB
+$43.1M
3
AZN icon
AstraZeneca
AZN
+$39.1M
4
AXSM icon
Axsome Therapeutics
AXSM
+$32M
5
A icon
Agilent Technologies
A
+$27.5M

Sector Composition

Rank Sector Weight
1 Healthcare 91.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$119M 5.26%
1,091,840
– –
LLY icon
2
Eli Lilly
LLY
$1.07T
$103M 4.53%
298,643
– –
PEN icon
3
Penumbra
PEN
$12.5B
$100M 4.43%
360,030
– –
CYTK icon
4
Cytokinetics
CYTK
$11B
$84.4M 3.73%
2,399,545
– –
HUM icon
5
Humana
HUM
$46.7B
$80.6M 3.56%
166,066
– –
CNC icon
6
Centene
CNC
$31.3B
$70.3M 3.11%
1,112,480
– –
IRTC icon
7
iRhythm Holdings
IRTC
$3.59B
$60.2M 2.66%
485,468
-8,253
-2% -$895K
UNH icon
8
UnitedHealth
UNH
$382B
$54.9M 2.42%
116,067
– –
EW icon
9
Edwards Lifesciences
EW
$47.6B
$53.7M 2.37%
648,633
+118,603
+22% +$9.32M
DXCM icon
10
DexCom
DXCM
$27.6B
$49.2M 2.17%
423,816
+288,351
+213% +$32.3M
MRK icon
11
Merck
MRK
$324B
$49.1M 2.17%
461,118
+93,484
+25% +$10.1M
CAH icon
12
Cardinal Health
CAH
$53.4B
$48.3M 2.13%
639,783
– –
ABBV icon
13
AbbVie
ABBV
$458B
$46M 2.03%
288,903
-40,441
-12% -$6.18M
ISRG icon
14
Intuitive Surgical
ISRG
$121B
$45.7M 2.02%
178,863
+64,413
+56% +$15.9M
SGEN
15
DELISTED
Seagen Inc. Common Stock
SGEN
$44.7M 1.98%
220,883
+28,499
+15% +$4.57M
DHR icon
16
Danaher
DHR
$135B
$44.3M 1.96%
198,178
– –
HUM icon
17
PUT
Humana
HUM
$46.7B
$42.7M 1.88%
+87,900
New +$43.5M
QURE icon
18
uniQure
QURE
$2.68B
$42.5M 1.88%
2,110,070
-192,244
-8% -$4.03M
SNDX icon
19
Syndax Pharmaceuticals
SNDX
$1.84B
$41.1M 1.82%
1,946,652
+132,018
+7% +$3.28M
IQV icon
20
IQVIA
IQV
$34.7B
$40M 1.77%
201,037
-28,044
-12% -$5.99M
HCA icon
21
HCA Healthcare
HCA
$84.8B
$39.2M 1.73%
148,500
+56,555
+62% +$14.4M
ARGX icon
22
argenx
ARGX
$57.4B
$39M 1.72%
104,732
– –
MOH icon
23
Molina Healthcare
MOH
$10.3B
$38.5M 1.7%
143,779
– –
MCK icon
24
McKesson
MCK
$98.5B
$37.7M 1.66%
105,811
– –
PRTA icon
25
Prothena Corp
PRTA
$458M
$37.5M 1.66%
774,546
-100,918
-12% -$5.33M
1
2 3 4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q1 2023 Portfolio in Review

As of Q1 2023, PFM Health Sciences held 101 positions worth $2.26B, down 19% from $2.79B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

PFM Health Sciences withdrew a net $492M in Q1 2023, closing 23 positions and reducing 23 holdings. Its most notable exit was Cigna, an estimated $46.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 81% a quarter earlier.

Against the trend, PFM Health Sciences opened a new position in Becton Dickinson worth $37.4M.

  • PFM Health Sciences's largest Q1 2023 buy was Becton Dickinson: 151,013 shares worth $37.4M.
  • PFM Health Sciences added most to DexCom in Q1 2023, an estimated $32.3M increase.
  • PFM Health Sciences's biggest Q1 2023 reduction was Axsome Therapeutics, cutting an estimated $32M.
  • PFM Health Sciences fully exited Cigna in Q1 2023, selling an estimated $46.8M.
  • PFM Health Sciences's ten largest holdings make up 35% of its $2.26B portfolio in Q1 2023.
  • PFM Health Sciences opened 12 new positions and closed 23 in Q1 2023.
  • PFM Health Sciences's portfolio value fell 19% quarter-over-quarter to $2.26B.

Based on PFM Health Sciences's 13F filing for Q1 2023, filed 15 May 2023.